First-in-human trial results of RET targeted BLU-667

Treating RET alterations with novel therapy BLU-667

Tandem duplications in triple negative breast cancer

Analysis tools for NCI genomic databases

Results from GOBACK: Non-chromosomal birth defects linked with cancer

A link between non-chromosomal birth defects and cancer

Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes

One off PSA prostate screening for men does not save lives

The Integrative Cancer Epidemiology Programme

Editor’s Choice for March 2018

Management of marker negative stage II testicular cancer

Mechanisms controlling genome integrity